Hallura

Hyaluronic Acid Dermal Fillers for Aesthetic Medicine

Health Tech & Life Sciences
Active
Series A Yokne'am Illit Founded 2017
Total raised
$7.0M
Last: Series A 2019-11
Stage
Series A
Founded
2017
Headcount
22
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

Hallura is building a new technology platform for the creation of the next generation of dermal fillers for aesthetic medicine. Designed to overcome the limitations of current products, Halluras HA Dermal Fillers are answering the growing demand for soft, natural, noninvasive aesthetic treatments. The companys products are based on its proprietary cross-linking technology, which uses a novel cross-linking mechanism to maintain and protect natural HA long chains. Hallura has completed a full set of in vivo animal studies of its products, demonstrating excellent safety and a higher potential for skin lifting compared with other leading products currently on the market.

Funding history · 2 rounds · $7.0M total

2019-11
Series A $7.0M
Date unknown
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyCosmetic Materials
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesCosmeticsMedical Devices IndustryHealthcare
Business model
B2C

Highlights

1 PatentsVerified

Tags

skin-careanti-agingcosmeticsdermatologynon-invasive